Nicobright Mint (Nicotine Resinate)

Nicotine Resinate, the active ingredient in Nicobright Mint, is a nicotine salt presented as an oral formulation for oral use. It delivers nicotine in a controlled manner to reduce cravings and ease the transition away from tobacco, helping adult smokers manage withdrawal symptoms.\n\nGNH India supplies Nicobright Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions.

Nicotine Resinate in Nicobright Mint is used as a nicotine replacement therapy to aid smoking cessation.\n\nSmoking cessation: assists adults in reducing nicotine cravings and withdrawal symptoms when quitting tobacco.\nAdjunct to behavioral counseling: supports patients undergoing structured cessation programs.\nTobacco dependence: provides a controlled nicotine source to replace cigarettes in dependent individuals.

Common Side Effects:\n- Nausea or upset stomach\n- Mouth or throat irritation\n- Headache\n- Dizziness\n- Insomnia or sleep disturbances\n- Increased salivation\n\nSerious or Rare Side Effects:\n- Elevated blood pressure or heart rate\n- Chest pain or palpitations\n- Severe allergic reaction (rash, swelling, difficulty breathing)\n- Persistent vomiting\n- Mood changes or depression\n- Unexplained fainting

Precautions for Nicobright Mint should be observed to ensure safe use.\n\nCardiovascular disease: use with caution in patients with hypertension, arrhythmia, or coronary disease.\nPregnancy and lactation: consult a healthcare professional before use.\nConcurrent nicotine products: avoid using other nicotine replacement therapies simultaneously.\nMedication interactions: review all current medicines with a clinician.\nUnderlying psychiatric conditions: monitor for mood changes.\nStore below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicobright Mint may interact with other substances that affect nicotine metabolism or cardiovascular function.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs): may amplify nicotine effects.\n- Other nicotine replacement products: risk of nicotine overdose.\n- Certain antihypertensive drugs: may reduce blood pressure control.\n\nModerate Interactions (Monitor Closely):\n- Caffeine: can increase nervousness or heart rate.\n- Alcohol: may enhance dizziness or nausea.\n- Some antidepressants (e.g., bupropion): may affect nicotine tolerance.